PROCEPT BioRobotics Corporation Increase (Decrease) in Interest Payable, Net
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Interest Payable, Net of $100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for the quarter ending 2026-06-30 was $51.00K, a 88.89% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for the quarter ending 2026-03-31 was $49.00K, a 96.00% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for the quarter ending 2025-12-31 was $48.00K, a 41.18% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for the quarter ending 2025-09-30 was $42.00K, a 23.53% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for fiscal 2025 was $142.00K, a 5.97% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for fiscal 2024 was $134.00K, a 7.20% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for fiscal 2023 was $125.00K, a 83.49% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in interest payable, net for fiscal 2022 was $757.00K, a 27.56% decline from fiscal 2021.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $100.00K 10-Q · filed 2026-08-05 | $148.00K derived: sum of 3 quarters · filed 2026-08-05 | $190.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $49.00K 10-Q · filed 2026-04-30 | $97.00K derived: sum of 2 quarters · filed 2026-04-30 | $139.00K derived: sum of 3 quarters · filed 2026-04-30 | $166.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $90.00K derived: sum of 2 quarters · filed 2026-02-26 | $117.00K derived: sum of 3 quarters · filed 2026-08-05 | $142.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $69.00K derived: sum of 2 quarters · filed 2026-08-05 | $94.00K 10-Q · filed 2025-11-05 | $128.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $52.00K 10-Q · filed 2026-08-05 | $86.00K derived: sum of 3 quarters · filed 2026-08-05 | $120.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $25.00K 10-Q · filed 2026-04-30 | $59.00K derived: sum of 2 quarters · filed 2026-04-30 | $93.00K derived: sum of 3 quarters · filed 2026-04-30 | $127.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $68.00K derived: sum of 2 quarters · filed 2026-02-26 | $102.00K derived: sum of 3 quarters · filed 2026-02-26 | $134.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $68.00K derived: sum of 2 quarters · filed 2025-11-05 | $100.00K 10-Q · filed 2025-11-05 | $132.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $66.00K 10-Q · filed 2025-08-07 | $98.00K derived: sum of 3 quarters · filed 2026-02-26 | $130.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-02 | $64.00K derived: sum of 2 quarters · filed 2026-02-26 | $96.00K derived: sum of 3 quarters · filed 2026-02-26 | $129.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $64.00K derived: sum of 2 quarters · filed 2026-02-26 | $97.00K derived: sum of 3 quarters · filed 2026-02-26 | $125.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $65.00K derived: sum of 2 quarters · filed 2024-10-28 | $93.00K 10-Q · filed 2024-10-28 | $162.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $61.00K 10-Q · filed 2024-08-02 | $130.00K derived: sum of 3 quarters · filed 2025-02-27 | $315.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $28.00K 10-Q · filed 2024-05-02 | $97.00K derived: sum of 2 quarters · filed 2025-02-27 | $282.00K derived: sum of 3 quarters · filed 2025-02-27 | $535.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $254.00K derived: sum of 2 quarters · filed 2025-02-27 | $507.00K derived: sum of 3 quarters · filed 2025-02-27 | $757.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $438.00K derived: sum of 2 quarters · filed 2023-11-02 | $688.00K 10-Q · filed 2023-11-02 | $929.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $503.00K 10-Q · filed 2023-07-28 | $744.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $250.00K 10-Q · filed 2023-05-04 | $491.00K derived: sum of 2 quarters · filed 2024-02-28 | $763.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $513.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.14M derived: sum of 3 quarters · filed 2024-02-28 | $1.04M 10-K · filed 2024-02-28 |
| 2021-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $896.00K derived: sum of 2 quarters · filed 2022-11-04 | $804.00K 10-Q · filed 2022-11-04 | $987.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $624.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $532.00K 10-Q · filed 2022-08-05 | $715.00K derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | -$92.00K 10-Q · filed 2022-05-06 | $91.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.05M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $866.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |